Jaydip Ghadage's Blog

Hysteroscopy Procedures Market Current and Future Demand, Analysis, Growth and Forecast By 2032

Jaydip Ghadage's photo
Jaydip Ghadage
·

3 min read

The Hysteroscopy Procedures Market was estimated at US$ 3.7 Billion in 2021 and is anticipated to grow at a CAGR of 8.4% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach a valuation of US$ 9.0 Billion.

The value of hospitals increased at a CAGR of roughly 8.2% between 2017 and 2021 due to a higher volume of patients for gynecological operations than other healthcare facilities. Any crisis that may emerge during or after medical treatments can be handled by the hospitals. Furthermore, hospitals offer a wide range of treatments, which will help the business thrive in the forthcoming years.

Get a PDF Sample with the Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15807

According to the National Library of Medicine, about 30 thousand myomectomies for fibroids are performed in the United States each year. Furthermore, since hospitals provide primary healthcare in the majority of countries, the number of hysteroscopy procedures conducted in hospitals is larger than in other healthcare institutions. The primary revenue drivers influencing the Hysteroscopy Procedures Market include the rising prevalence of gynecological illnesses such as ovarian cancer, uterine fibroids, and ovarian cysts, as well as the global trend toward minimally invasive surgery.

Ovarian cysts are highly frequent in females; wherein around 7% of women globally are reported to have ovarian cysts. In the United States, there are 15 cases per 100 thousand women per year. Women ovarian cysts are seen in 18% of postmenopausal women and are prevalent in all premenopausal women. The usage of hysteroscopy procedures in hospitals, clinics, and ambulatory surgical centres is increasing due to a growth in the number of gynecological illnesses.

Minimally invasive surgery is a medical procedure that involves the use of a hysteroscope, which is a thin, lighted tube that is inserted into the uterus through the cervix.

Competitive Landscape

  • Medtronic

  • Stryker Corporation

  • Hologic Inc.

  • KARL STORZ SE & Co. KG

  • Medical devises Business Services Inc.

  • Olympus Corporation

  • Delmont Imaging

  • CooperCompanies

  • Richard Wolf GmbH

  • B. Braun Melsungen AG

  • Maxer Endoscopy GmbH

  • Boston Scientific Corp.

  • MedGyn Products, Inc.

  • Meditrina, Inc. (Aveta)

  • Lina Medical APS

  • Luminelle

Some of the recent developments of key Hysteroscopy Procedures market providers are as follows:

  • In May 2020, Olympus Corporation signed an agreement with UVision 360 to market its LUMINELLE DTx hysteroscopy equipment in the United States with an objective to strengthen and continue growth in United States hysteroscopy procedure market.

  • In November 2019, the AvetaTM Hysteroscopy System has been introduced by Meditrina, Inc. during American Association of Gynecologic Laparoscopists convention. The launch of new product will help Meditirna, Inc to strengthen its position in the market and expand its hysteroscopy procedure product portfolio.

  • In January 2019, Hologic Inc. launched the Omni hysteroscope in the United States, a three-in-one modular scope with superior imaging capabilities suited for both diagnostic and therapeutic hysteroscopic end uses.

To learn more about this report @ https://www.futuremarketinsights.com/reports/hypsteroscopy-procedures-market

Hysteroscopy Procedures Market Segmentation

By End Use:

  • Hospitals

  • Clinics

  • Ambulatory Surgery Centers (ASCs)

Hysteroscopy Procedures Market